Depression and visual functioning in XXXX with ocular inflammatory disease.

@entity1 @entity308
PURPOSE: To characterize the level of @entity308 in @entity1 with ocular inflammatory disease and to determine predictors of @entity308 in this population. DESIGN: Prospective cross-sectional survey and medical record review. METHODS: @entity1 were consecutive @entity1 with noninfectious ocular inflammatory disease in a university-based tertiary referral center. Subjects were given the self-administered Beck @entity308 Inventory-II (BDI-II), National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25), and additional supplemental questions. Medical records were reviewed for clinical characteristics. Univariate analyses were conducted to compare clinical characteristics between @entity1 with and without a positive screen for @entity308 , and a multivariate regression model was performed to determine the most significant predictors of @entity308 . RESULTS: Of the 104 @entity1 , 26.9% screened positive for @entity308 with the BDI-II. Of these subjects, only 39.3% had been previously diagnosed with @entity308 . NEI VFQ-25 scores were significantly lower in @entity308 @entity1 in all subscales except driving and color vision. Predictors of @entity308 were inadequate emotional support, lower visual functioning (VFQ composite score), history of changing immunomodulatory treatment, and current oral corticosteroid use. CONCLUSIONS: @entity308 may be a significant but underrecognized comorbid condition in @entity1 with ocular inflammatory disease. Worse visual function was associated with @entity308 . The authors recommend heightened awareness of potential @entity308 in @entity1 with ocular inflammatory disease.
